Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

RENSCHLER MARKUS MD Create: Alert

All | News | Filings
Date FiledTypeDescription
02/07/2023 4 RENSCHLER MARKUS MD (President and CEO) has filed a Form 4 on Cyteir Therapeutics, Inc.
Txns: Granted 5,000 shares @ $1.49, valued at $7.5k
Granted 302,600 options to buy @ $1.69, valued at $511.4k
02/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2021 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy